TLG RESOURCES INTERNATIONAL LLC

Prepared By:

Nroop Bhavsar

Bhumika Gandhi

Madoka Noto

Guided By:

Professor Fulda

Professor Maddaloni

PRESENTATION OUTLINE

COMPANY DESCRIPTION, VISION & GOALS

SERVICES & PRODUCTS DESCRIPTION

BUSINESS STRATEGY

INDUSTORY OUTLOOK, MARKET TRENDS & ANALYSIS

COMPETITIVE ASSESSMENT

CUSTOMER ANALYSIS

MARKETING PLAN

FIANACIAL PLAN SUMMARY

CONCLUSION

COMPANY DESCRIPTION, VISION & GOALS

TLG resources International is a service designed business

Facilitation for procurement of API’s

Target market

Exclusive rights to sell API

VISION AND GOAL

Leading supply chain enabler

Enter into more contracts

Develop business

SERVICES & PRODUCTS DESCRIPTION

Import procedure

Issues with FDA

Entry documents

Quality of products

Order tracking service

TLG RESOURCE INTERNATIONAL

Blockbuster drugs’ API

APIs related to drugs of Central Nervous system

Anti Cancer

Cardio Vascular System

BUSINESS STRATEGY

Intensive Growth

Market Penetration Market Development Products and Services development

Integrative Growth

Strategic Alliance with API manufacturers

INDUSTORY OUTLOOK, MARKET TRENDS & ANALYSIS

Key Statistics for US Pharmaceutical marketCAGR 7.4%

Total Revenues (2006) $260.8 billions

Global pharma market share

48%

INDUSTORY OUTLOOK, MARKET TRENDS & ANALYSIS Biotechnology expansion Oncology growth Medicare part D Vaccines remain a bright spot Positive demographic trends

COMPETITIVE ASSESSMENTLeading Competitors Location Estimated

Annual Sales in $ Millions

Description of main line of business/ competitive advantage/ Attributes

Attix Pharmachem Canada -- o Global supplier of APIs, other fine chemicals, raw materials, intermediates and nutraceuticals

KBI Biopharma NC, USA 1.3 o Contract biopharmaceutical manufacturero API manufacturing for the partner company

Hovione NJ, USA 4.3 o API development and manufacturing

Ceres Chemical NY, USA -- o Consulting services between suppliers of API and pharmaceutical and biotech companies

TAPI ( Teva) NJ, USA -- o API manufacturer and supplier

Aesica UK 22 m GBP o Leading supplier of API

BASF NJ, USA -- o Manufacturer and supplier of raw chemicals and biologics

Flavine Holdings Inc. NJ, USA 56 o Manufacturer and suppliers of API

US PharmaLabs NJ, USA 25 o Supply chain enabler of APIs

SWOT ANALYSIS

•Pharma industry = New Jersey•Entrepreneur knows industry and network • Innovation

• Lack of Capital• Small size• Dependence on all types of APIs• No entrepreneurial experience • Difference in quality control

• Cost-effective. • Expansion of business with Indian and Chinese companies• Growing healthcare industry

• Competition from larger players and private labels.• Regulations• Foreign exchange changes: weak dollar

CUSTOMER ANALYSIS The U.S. companies need Chinese and Indian APIs for

the following reasons: Highly skilled in extraction and purification of

herbs and botanicals Highly skilled in fermentation of microorganisms Very competitive in synthesis of intermediates

and the finished APIs Being competitive in R-DNA biologics

Insights from customer survey On-time & speed-up delivery Convenient & quicker order processing Full certified compliance in handling & storage

MARKETING PLAN

Marketing strategies for services

Promotional Activities

TLG’s website Banners and Hoardings Direct Mailing to companies Magazines and Newspapers Pharmaceutical Conferences

BREAKDOWN OF MARKETING BUDGET

FIANACIAL PLAN SUMMARY

FINANCIAL PLAN SUMMARY

CONCLUSION & RECOMMENDATIONS

Growth potential